Development and pathology of the hyaloid, choroidal and retinal vasculature.

During embryogenesis, the development and differentiation of the eye requires the concomitant formation of the neural/glial elements along with a dense vascular network. The adult neural retina is supported by two distinct vascular systems, the proper retinal vessels and the choroidal vessels. The two beds differ not only in their pattern of embryonic differentiation, but also in their function in the adult organism. The retinal vasculature has barrier properties similar to those observed in the brain, whereas the choroidal vessels display a highly fenestrated phenotype. The hyaloid vasculature is a transient embryonic vascular bed which is complete at birth in mammals and regresses contemporaneously with the formation of the retinal vasculature. The dependence of the retina on its blood supply makes it highly vulnerable to any vascular changes and indeed ocular diseases, such as proliferative retinopathy, age-related macular degeneration and the hyperplastic primary vitreous, which are associated with abnormalities of the different vascular beds of the eye. A number of factors have been implicated in developmental and pathological changes in vessel formation and regression, including fibroblast growth factors, platelet-derived endothelial growth factor and vascular endothelial growth factor, among others. The purpose of this review is to describe and discuss new insights into the mechanisms and molecular cues involved in the development of the normal and pathological vascular systems of the eye. The characterization of the molecules and cell-cell interactions involved in the formation, stabilization and regression of new vessels has led to the identification of potential control points for therapeutic intervention.

[1]  C. Gerhardinger,et al.  Early cellular and molecular changes induced by diabetes in the retina , 2001, Diabetologia.

[2]  Ingeborg Stalmans,et al.  Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. , 2002, The Journal of clinical investigation.

[3]  Frederick A. Jakobiec,et al.  Ocular anatomy, embryology, and teratology , 1982 .

[4]  S. Rafii,et al.  Contribution of marrow-derived progenitors to vascular and cardiac regeneration. , 2002, Seminars in cell & developmental biology.

[5]  J. Bishop,et al.  Macrophages are required for cell death and tissue remodeling in the developing mouse eye , 1993, Cell.

[6]  M. Sunday,et al.  Differential expression of VEGF isoforms in mouse during development and in the adult , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[7]  P. Campochiaro,et al.  Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.

[8]  R W Young,et al.  Pathophysiology of age-related macular degeneration. , 1987, Survey of ophthalmology.

[9]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[10]  M. Gertsenstein,et al.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. , 1994, Genes & development.

[11]  Shay Soker,et al.  Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*) , 1996, The Journal of Biological Chemistry.

[12]  Y. Sharma,et al.  Vascular endothelial growth factor expression and signaling in the lens. , 2003, Investigative ophthalmology & visual science.

[13]  H. Etchevers,et al.  The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. , 2001, Development.

[14]  T. Chan-Ling,et al.  The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. , 1995, Investigative ophthalmology & visual science.

[15]  S. Nishikawa,et al.  PDGF Mediates a Neuron–Astrocyte Interaction in the Developing Retina , 1996, Neuron.

[16]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[17]  J. Stone,et al.  Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  C. Galambos,et al.  Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. , 2002, American journal of respiratory cell and molecular biology.

[19]  P T de Jong,et al.  Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.

[20]  S. Hayreh,et al.  Ocular neovascularization with retinal vascular occlusion. I. Association with experimental retinal vein occlusion. , 1982, Archives of ophthalmology.

[21]  S. Ryan,et al.  The role of retinal pigment epithelium in the involution of subretinal neovascularization. , 1986, Investigative ophthalmology & visual science.

[22]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[23]  P. D. de Jong,et al.  Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.

[24]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[25]  J. Folkman,et al.  Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .

[26]  G. Gole,et al.  Proximal arterial vasoconstriction precedes regression of the hyaloid vasculature , 2001, Current eye research.

[27]  D. Hinton,et al.  Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.

[28]  H. Kaplan,et al.  Débridement of the pig retinal pigment epithelium in vivo. , 1995, Archives of ophthalmology.

[29]  A Kijlstra,et al.  Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. , 1999, The American journal of pathology.

[30]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[31]  R. Nicosia,et al.  Regulation of Vascular Growth and Regression by Matrix Metalloproteinases in the Rat Aorta Model of Angiogenesis , 2000, Laboratory Investigation.

[32]  K. Nakagawa,et al.  Expression of vascular endothelial growth factor in experimental choroidal neovascularization , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.

[33]  P. Campochiaro,et al.  Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina , 2000, Journal of cellular physiology.

[34]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[35]  J. Stone,et al.  Development of retinal vasculature in the cat: processes and mechanisms. , 1990, Current eye research.

[36]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[37]  N. Fukai,et al.  Lack of collagen XVIII/endostatin results in eye abnormalities , 2002, The EMBO journal.

[38]  A Mathis,et al.  Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. , 1994, Archives of ophthalmology.

[39]  K. Csaky,et al.  Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. , 2000, Investigative ophthalmology & visual science.

[40]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[41]  L. Ment,et al.  Astrocyte-derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro. , 2001, Brain research. Developmental brain research.

[42]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[43]  H. Ueno,et al.  Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration , 2000, Gene Therapy.

[44]  B. Hogan,et al.  Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure , 2001, BMC Genetics.

[45]  P. Overbeek,et al.  Regulation of choroid development by the retinal pigment epithelium. , 2001, Molecular vision.

[46]  J. Ash,et al.  Lens-specific VEGF-A expression induces angioblast migration and proliferation and stimulates angiogenic remodeling. , 2000, Developmental biology.

[47]  C. Hartmann,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[48]  M. Merrill,et al.  Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. , 1995, Growth factors.

[49]  K. Gogat,et al.  VEGF and KDR gene expression during human embryonic and fetal eye development. , 2004, Investigative ophthalmology & visual science.

[50]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[51]  P. Campochiaro,et al.  Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. , 2004, American journal of ophthalmology.

[52]  W. Feichtinger,et al.  Future Aspects in Human In Vitro Fertilization , 1987, Springer Berlin Heidelberg.

[53]  K. Hirschi,et al.  Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. , 1999, Circulation research.

[54]  Hung V. Nguyen,et al.  The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.

[55]  S. Sarks,et al.  Ageing and degeneration in the macular region: a clinico-pathological study. , 1976, The British journal of ophthalmology.

[56]  J. Provis,et al.  Development of the human retinal vasculature: cellular relations and VEGF expression. , 1997, Experimental eye research.

[57]  J. Stone,et al.  Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. , 1996, Investigative ophthalmology & visual science.

[58]  P. Campochiaro,et al.  Angiopoietin‐2 plays an important role in retinal angiogenesis , 2002, Journal of cellular physiology.

[59]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[60]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[61]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[62]  D. Noden Embryonic origins and assembly of blood vessels. , 1989, The American review of respiratory disease.

[63]  H. Nakamura,et al.  Electron microscopic study of the prenatal development of the thoracic aorta in the rat. , 1988, The American journal of anatomy.

[64]  Marcus Fruttiger,et al.  Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. , 2002, Investigative ophthalmology & visual science.

[65]  R. Lang,et al.  Apoptosis during macrophage-dependent ocular tissue remodelling. , 1994, Development.

[66]  Joan W. Miller,et al.  Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. , 2002, Investigative ophthalmology & visual science.

[67]  T. L. Murphy,et al.  Vessel formation by choroidal endothelial cells in vitro is modulated by retinal pigment epithelial cells. , 1995, Archives of ophthalmology.

[68]  P. Campochiaro,et al.  Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. , 1998, The American journal of pathology.

[69]  I J Constable,et al.  Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. , 2000, The American journal of pathology.

[70]  C. Distler,et al.  Müller cells in vascular and avascular retinae: A survey of seven mammals , 1992, The Journal of comparative neurology.

[71]  M. Killingsworth,et al.  Evolution of geographic atrophy of the retinal pigment epithelium , 1988, Eye.

[72]  P. Campochiaro,et al.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. , 2002, Developmental cell.

[73]  Joyce Tombran-Tink,et al.  Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. , 2002, Investigative ophthalmology & visual science.

[74]  Shahin Rafii,et al.  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003, Nature Medicine.

[75]  Joan W. Miller,et al.  Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. , 2002, Archives of ophthalmology.

[76]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[77]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.

[78]  J. Marshall,et al.  Age-related variation in the hydraulic conductivity of Bruch's membrane. , 1995, Investigative ophthalmology & visual science.

[79]  Y. Tano,et al.  Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells. , 2000, American journal of ophthalmology.

[80]  F. Zindy,et al.  The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[81]  T. Doetschman,et al.  Blastocyst-Derived Embryonic Stem Cells as a Model for Embryogenesis , 1987 .

[82]  T. Chan-Ling,et al.  Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. , 2000, Investigative ophthalmology & visual science.

[83]  P. Schimmel,et al.  Bone marrow–derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis , 2002, Nature Medicine.

[84]  Jian-xing Ma,et al.  Unbalanced expression of VEGF and PEDF in ischemia‐induced retinal neovascularization , 2001, FEBS letters.

[85]  J. Stone,et al.  Supplemental oxygen therapy. Basis for noninvasive treatment of retinopathy of prematurity. , 1995, Investigative ophthalmology & visual science.

[86]  D. S. Mcleod,et al.  Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. , 2002, Investigative ophthalmology & visual science.

[87]  M. Goldberg Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. , 1997, American journal of ophthalmology.

[88]  W. Shen,et al.  In vivo use of oligonucleotides to inhibit choroidal neovascularisation in the eye , 2001, The journal of gene medicine.

[89]  R. Lang,et al.  A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. , 1996, Development.

[90]  R W Flower,et al.  Postnatal retinal vascular development of the puppy. , 1985, Investigative ophthalmology & visual science.

[91]  T. J. Poole,et al.  Embryonic vascular development: immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos. , 1988, Development.

[92]  R W Flower,et al.  Visualization of a developing vasculature. , 1987, Microvascular research.

[93]  V. Reppucci,et al.  RPE destruction causes choriocapillary atrophy. , 1984, Investigative ophthalmology & visual science.

[94]  W. Risau,et al.  Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: A role for vascular endothelial growth factor as a survival factor for endothelium , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[95]  J. Winer,et al.  Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. , 1992, The Journal of biological chemistry.

[96]  W R Green,et al.  Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.

[97]  D. Shima,et al.  The Mouse Gene for Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.

[98]  R. Engerman,et al.  Cell turnover of capillaries. , 1967, Laboratory investigation; a journal of technical methods and pathology.

[99]  J. Stone,et al.  The role of müller cells in the formation of the blood-retinal barrier , 1993, Neuroscience.

[100]  J. Tombran-Tink,et al.  Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes. , 2002, Biochemical and biophysical research communications.

[101]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[102]  M. Zarbin,et al.  Ultrastructural analysis of hydraulic and abrasive retinal pigment epithelial cell debridements. , 2003, Experimental eye research.

[103]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[104]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[105]  R. D'Amato,et al.  Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. , 2001, The American journal of pathology.

[106]  S. Seregard,et al.  Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.

[107]  D. Darland,et al.  Cell-cell interactions in vascular development. , 2001, Current topics in developmental biology.

[108]  D. Yew,et al.  Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats , 1998, Experimental Brain Research.

[109]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[110]  Joan W. Miller,et al.  Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. , 1996, Investigative ophthalmology & visual science.

[111]  M Aguet,et al.  VEGF is required for growth and survival in neonatal mice. , 1999, Development.

[112]  A. Hendrickson,et al.  Astrocytes and blood vessels define the foveal rim during primate retinal development. , 2000, Investigative ophthalmology & visual science.

[113]  D. Eliott,et al.  Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.

[114]  E. Piek,et al.  Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. , 2003, Developmental biology.

[115]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[116]  O. Volpert,et al.  Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. , 2002, American journal of ophthalmology.

[117]  J. Nathans,et al.  Vascular Development in the Retina and Inner Ear Control by Norrin and Frizzled-4, a High-Affinity Ligand-Receptor Pair , 2004, Cell.

[118]  I. C. Michaelson,et al.  Effect of Increased Oxygen on the Development of the Retinal Vessels * , 1954, The British journal of ophthalmology.

[119]  P. Ratcliffe,et al.  Oxygen sensors and angiogenesis. , 2002, Seminars in cell & developmental biology.

[120]  R. Lang,et al.  VEGF deprivation-induced apoptosis is a component of programmed capillary regression. , 1999, Development.

[121]  Lois E. H. Smith,et al.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[122]  E. Scott,et al.  Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization , 2002, Nature Medicine.

[123]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[124]  L. Pardanaud,et al.  Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. , 1989, Development.

[125]  T. Chan-Ling,et al.  Astrocyte-endothelial cell relationships during human retinal vascular development. , 2004, Investigative ophthalmology & visual science.

[126]  D. Eliott,et al.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[127]  A. Bikfalvi,et al.  Involvement of fibroblast growth factors in choroidal angiogenesis and retinal vascularization. , 2003, Experimental eye research.

[128]  M. Spitznas,et al.  Ultrastructure of the human posterior tunica vasculosa lentis during early gestation , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[129]  Erwin P. Bottinger,et al.  Biology of TGF-β in knockout and transgenic mouse models , 1997 .

[130]  W. Manning,et al.  AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. , 2003, Investigative ophthalmology & visual science.

[131]  M. Yoshioka,et al.  Regression of the hyaloid vessels and pupillary membrane of the mouse , 1999, Anatomy and Embryology.

[132]  M. Uyama,et al.  Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. , 1996, Current eye research.